[
    [
        {
            "time": "2019-03-27",
            "original_text": "Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe",
            "features": {
                "keywords": [
                    "Novartis",
                    "Approval",
                    "MS Drug",
                    "Mayzent",
                    "Europe"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-08-14",
            "original_text": "Puma Biotech's (PBYI) Breast Cancer Drug Nerlynx Aids Growth",
            "features": {
                "keywords": [
                    "Puma Biotech",
                    "Breast Cancer",
                    "Drug Nerlynx",
                    "Growth"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-06-12",
            "original_text": "Jazz's (JAZZ) New Sleep Drug Sunosi Gets Approval in Europe",
            "features": {
                "keywords": [
                    "Jazz",
                    "New Sleep Drug",
                    "Sunosi",
                    "Approval",
                    "Europe"
                ],
                "sentiment_score": 0.88,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]